1312811-00-9CC(=O)OC[C@H]1O[C@@H](c2ccc(C)c(C(=O)c3ccc(-c4ccc(F)cc4)s3)c2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=OCCDRJKIEGRVBAT-CANUFQTHSA-N1312811-00-9DTXSID50717994Verwenden[5-(4-fluorophenyl)-2-thienyl][2-methyl-5-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)phenyl]-methanone is an intermediate in the synthesis of Canagliflozin which is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…